Latin America Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.

Press releases published on October 26, 2026

Oct. 26, 2026

SRX Global Announces Activation of the University of California, Davis as a Clinical Trial Site for CERo Therapeutics’ Ongoing Phase 1 CERTAIN-T Trial of CER-1236 in Hematologic Malignancies

Indeterminate GlobeNewswire

Oct. 26, 2026

Imprivata Recognized for the First Time in the Gartner® Magic Quadrant™ for Privileged Access Management

Indeterminate GlobeNewswire

Oct. 26, 2026

Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call

Indeterminate GlobeNewswire

Oct. 26, 2026

Immuno-Oncology Emerges as a Major Force in the Global Cancer Treatment Market

Indeterminate GlobeNewswire

Oct. 26, 2026

More Than 1 in 10 People Receive Medically Actionable Genetic Results Through 23andMe, Analysis of Nearly 6 Million Participants Finds

Indeterminate GlobeNewswire

Oct. 26, 2026

Avacta Group plc: Faridoxorubicin Treatment Results in Near Doubling of Progression-Free Survival and Clinically Meaningful Tumor Shrinkage in Most Patients with Salivary Gland Cancers

Indeterminate GlobeNewswire

Oct. 26, 2026

Medicenna Reports Potent CD122 Blockade and Extended Survival with MDNA209 in Preclinical Models of Autoimmune Disease

Indeterminate GlobeNewswire

Oct. 26, 2026

Ambros Therapeutics Announces Planned Interim Analysis of Phase 3 Clinical Trial Following FDA Feedback

Indeterminate GlobeNewswire

Oct. 26, 2026

Daré Bioscience to Showcase Its Investigational Programmable Device, DARE-IDDS, at PODD 2026: One Device, Designed to Deliver 100+ Doses and to be Controlled Wirelessly

Indeterminate GlobeNewswire

Oct. 26, 2026

Propanc Biopharma Publishes New Data: PRP Reprograms Chemotherapy-Resistant Pancreatic Cancer Cells & Restores Therapeutic Vulnerability

Indeterminate GlobeNewswire

Oct. 26, 2026

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Oct. 26, 2026

CytoDyn Presents Updated Leronlimab Data in Metastatic Colorectal Cancer at ESMO Congress 2026

Indeterminate GlobeNewswire

Oct. 26, 2026

SS Innovations Showcases SSi Mantra Telesurgery Capabilities at October 2026 Conferences

Indeterminate GlobeNewswire

Oct. 26, 2026

Weight Watchers Schedules Third Quarter 2026 Earnings Conference Call

Indeterminate GlobeNewswire

Oct. 26, 2026

Equillium Announces First Subject Dosed in Phase 1 Clinical Trial of EQ504

Indeterminate GlobeNewswire

Oct. 26, 2026

Nuvectis Reports Positive Data from NXP200 Phase 1b Study Demonstrating Durable Responses, Including Complete Responses, in BRAF V600-mutated Recurrent or Progressive Gliomas

Indeterminate GlobeNewswire

Oct. 26, 2026

Senseonics Initiates First-in-Human Study of Freedom, Designed to be the World’s First CGM System with No On-body Component

Indeterminate GlobeNewswire

Oct. 26, 2026

Affordable Pet Labs Launches Nationwide Validation Study of an At-Home Heartworm Test, and Invites Dog Owners in 52 Cities to Help

Indeterminate GlobeNewswire

Oct. 26, 2026

Stryker completes acquisition of ZuriMED to enhance its shoulder offering

Indeterminate GlobeNewswire

Oct. 26, 2026

GT Biopharma Selected for Oral Presentation at the SITC 2026 Annual Meeting

Indeterminate GlobeNewswire